Global In-Vitro Lung Model Market 2018-2023 - Analysis by Type and Application - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--Jun 5, 2018--The “In Vitro Lung Model Market by Type (2D, 3D (In-house, Commercial)), Application (Drug Screening, Toxicology, 3D Model Development, Basic Research, Physiologic Research, Stem Cell Research, Regenerative Medicine) - Global Forecasts to 2023” report has been added to ResearchAndMarkets.com’s offering.
The lung in vitro models market is expected to reach USD 427.4 million by 2023 from an estimated USD 190.5 million in 2018, at a CAGR of 17.5%.
Focus on developing alternatives for animal testing models, advancements in 3D cell culture technology, and the development of new 3D in vitro models are factors driving the growth of this market. However, the dearth of skilled professionals is expected to challenge market growth during the forecast period.
The lung in vitro models market is segmented into 2D cell models and 3D cell models. 3D cell models are further segmented into in-house 3D models and commercialized 3D models (ready-to-use). The 3D cell models segment is projected to grow at the fastest rate during the forecast period owing to the rising need for efficient lung in vitro models that mimic in vivo physiology.
Based on application, the market is segmented applications of 2D models and 3D models. Applications of 2D models include drug discovery and toxicology, 3D model development, and basic research and the applications of 3D models include drug discovery and toxicology, physiological research, and stem cell research & regenerative medicine. The drug discovery and toxicology segment of 3D models are also expected grow at the highest CAGR in 2018.
Key Topics Covered
2 Research Methodology
3 Executive Summary
4 Market Dynamic
5 In Vitro Lung Model Market, By Type
6 In Vitro Lung Model Market, By Application
7 In Vitro Lung Model Market, By Region
8 Competitive Landscape
9 Company ProfilesATCC Lonza Epithelix Mattek Emulate Tissuse Mimetas Insphero CN Bio Innovations
For more information about this report visit https://www.researchandmarkets.com/research/rsdgf4/global_invitro?w=4
View source version on businesswire.com:https://www.businesswire.com/news/home/20180605005846/en/
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics:In Vitro Diagnostics
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY GENETICS
SOURCE: Research and Markets
Copyright Business Wire 2018.
PUB: 06/05/2018 06:33 AM/DISC: 06/05/2018 06:33 AM